http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3397258-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7a315315c6f04176772cce3218ecd23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89db6a3c8c545ee76027520ee2b2327e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_caeac6576d5f202c6e870925c177f1a0 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 |
| filingDate | 2016-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b6f89564dfa926b46fecf2251e34a11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_575ebdb3907372d01d26acc9cac4eb2a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e127eff0307245a98423e49d2cdfdc9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96f53c845ed968737615c566ff89ace1 |
| publicationDate | 2018-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-3397258-A2 |
| titleOfInvention | Use of brassinosteroid analogs for the treatment of dermal disorders by selectively modulating liver x receptors (lxr) and dermal disease treatment by brassinosteroid analogs acting as selective liver x receptor (lxr) modulators |
| abstract | The present invention relates to the use of brassinosteroid analogs for the treatment of dermal disorders or conditions. One embodiment is the topical application of at least one brassinosteroid analog described herein for the treatment of psoriasis in a mammal. The present invention describes the use of brassinosteroid analogs of general formula (a). (a) (I) wherein, R 1 , R 2 , and R3 are selected from H, H0-, linear or branched C1-C4 alkyl, R 5 -O-, HCOO-, R 5 -COO-, -OOC-R 6 -COO-, p-toluene sulphonate, phosphate, tartrate, maleate, sulphate, fluorine, chlorine, bromine, iodine and methanesulphonate, R 4 and R 5 are selected from H and linear or branched C1-C4 alkyl, R 6 is -(CH2)n- wherein n equals to 1, 2 or 3, and can be a single or double bond An embodiment of the present invention describes a method of therapeutic treatment for psoriasis, skin aging, rosacea, dermatitis, burns, skin cancer and malignancies, and pigmentary derangements, by means of administration of brassinosteroid analogs of general formula (a). |
| priorityDate | 2015-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 110.